Literature DB >> 30322455

What is new in the battle against postoperative nausea and vomiting?

Vahé S Tateosian1, Katelynn Champagne2, Tong J Gan2.   

Abstract

The issue of postoperative nausea and vomiting (PONV) still poses a significant burden on our patients. Although rarely associated with a life-threatening condition, it is consistently considered as one of the most undesirable side effects of surgery and anesthesia. There are well-established risk factors for the development of PONV that include patient-related factors, anesthetic technique, use of volatile anesthetics, use of nitrous oxide, duration of anesthesia, opioid administration, and type of surgery. Because pharmacologic interventions for PONV are not without risks, practitioners must assess patient's risk status from low to high and consider the benefits of treatment. This review summarizes the current state of knowledge related to PONV and provides a practical approach toward risk assessment, prevention, and numerous treatment strategies.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NK-1 receptor antagonists; PONV combination therapy; PONV treatment strategies; dopamine antagonists; postoperative nausea and vomiting (PONV) risk assessment; serotonin receptor antagonists

Mesh:

Substances:

Year:  2018        PMID: 30322455     DOI: 10.1016/j.bpa.2018.06.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  10 in total

Review 1.  Postoperative Nausea and Vomiting in Pediatric Patients.

Authors:  Anthony L Kovac
Journal:  Paediatr Drugs       Date:  2020-10-27       Impact factor: 3.022

2.  Perioperative Administration of Emend® (Aprepitant) at a Tertiary Care Children's Hospital: A 12-Month Survey.

Authors:  Anuradha Kanaparthi; Sarah Kukura; Natalie Slenkovich; Faris AlGhamdi; Shabana Z Shafy; Mohammed Hakim; Joseph D Tobias
Journal:  Clin Pharmacol       Date:  2019-11-27

Review 3.  Roadmap to the Enhanced Thoracic Surgical Journey.

Authors:  TaCharra Y D Woodard; Carla M Patel; Garrett L Walsh
Journal:  J Adv Pract Oncol       Date:  2021-01-01

4.  The Utilization and Diagnostic Yield of Upper Endoscopy for Evaluation of Gastrointestinal Symptoms Within the First Year After Liver Transplantation.

Authors:  Ebubekir Daglilar; Sean E Connolly; Veysel Tahan; Ari Cohen; George Therapondos
Journal:  Cureus       Date:  2020-11-04

Review 5.  Role of general anesthetic agents in postoperative nausea and vomiting: A review of literature.

Authors:  Shilpa Sunil Khanna; Muqthadir Siddiqui Mohammed Abdul; Urooj Fatima; Harshitha Garlapati; Mohd Abdul Qayyum; Sunil Kumar Gulia
Journal:  Natl J Maxillofac Surg       Date:  2022-06-15

6.  Effect of subarachnoid anesthesia combined with propofol target-controlled infusion on blood loss and transfusion for posterior total hip arthroplasty in elderly patients.

Authors:  Cheng-Shi Xu; Xiang-Dong Qu; Zhi-Jun Qu; Geng Wang; Huai-Jiang Wang
Journal:  Chin Med J (Engl)       Date:  2020-03-20       Impact factor: 2.628

7.  Acupuncture therapy on postoperative nausea and vomiting in abdominal operation: A Bayesian network meta analysis.

Authors:  Chengwei Fu; Tong Wu; Qing Shu; Aiqun Song; Yang Jiao
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

8.  Intraoperative systemic vascular resistance is associated with postoperative nausea and vomiting after laparoscopic hysterectomy.

Authors:  Meng-Di Qu; Meng-Yuan Zhang; Gong-Ming Wang; Zhun Wang; Xu Wang
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

9.  [Prevention of postoperative nausea and vomiting: new insights for patient care].

Authors:  André P Schmidt
Journal:  Braz J Anesthesiol       Date:  2020-09-11

10.  A comparison of noninvasive and invasive acupuncture in preventing postoperative nausea and vomiting: A protocol for systematic review and Bayesian network meta-analysis.

Authors:  Cheng-Wei Fu; Qing Shu; Yang Jiao; Tong Wu; Ai-Qun Song; Qiao-Chu Zhu; Wei-Ping Zhang
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.